An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence

L Ibáñez, SE Oberfield, S Witchel, RJ Auchus… - Hormone research in …, 2017 - karger.com
This paper represents an international collaboration of paediatric endocrine and other
societies (listed in the Appendix) under the International Consortium of Paediatric …

[HTML][HTML] Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association

S Arslanian, F Bacha, M Grey, MD Marcus… - Diabetes …, 2018 - ncbi.nlm.nih.gov
Although all types of diabetes result in hyperglycemia, the pathophysiology of each type of
diabetes is different. These guidelines summarize available data specific to the …

Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis

M Forslund, J Melin, S Alesi, T Piltonen… - European journal of …, 2023 - academic.oup.com
Objective To compare between different combined oral contraceptive pills (COCPs) as part
of the update of the International Evidence-Based Guidelines on the Assessment and …

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

E Diamanti-Kandarakis - Expert Reviews in molecular medicine, 2008 - cambridge.org
Polycystic ovarian syndrome (PCOS) is universally recognised as the commonest
endocrinopathy of women. The definition and the aetiological hypotheses of PCOS are …

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo …

K Hoeger, K Davidson, L Kochman… - The Journal of …, 2008 - academic.oup.com
Context: Polycystic ovary syndrome (PCOS) presents in adolescence, and obesity is a
common finding. The benefits and risks of alternate approaches to the management of …

Evaluation of Adverse Outcome in Young Women with Polycystic Ovary Syndrome Versus Matched, Reference Controls: A Retrospective, Observational Study

CL Morgan, S Jenkins-Jones, CJ Currie… - The Journal of Clinical …, 2012 - academic.oup.com
Context: Polycystic ovary syndrome (PCOS) is associated with insulin resistance,
hyperandrogenism, and dyslipidemia, but the effects of these disturbances on long-term …

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

A Bargiota… - Therapeutic advances in …, 2012 - journals.sagepub.com
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of
reproductive age that is associated with significant adverse short-and long-term health …

Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta‐analyses

H Teede, EC Tassone, T Piltonen… - Clinical …, 2019 - Wiley Online Library
Background Polycystic ovary syndrome (PCOS) has a prevalence of 8%‐13%. Given the
prevalence, diverse health impacts and variation in care, rigorous evidence‐based …

[HTML][HTML] Anti-androgen hormonal therapy for cancer and other diseases

S Student, T Hejmo, A Poterała-Hejmo… - European journal of …, 2020 - Elsevier
The development of targeted therapies has been a consistent goal for hormone-related
diseases treatment. As a result of increased knowledge of the role of androgens in different …

Polycystic ovary syndrome in the pediatric population

AA Bremer - Metabolic syndrome and related disorders, 2010 - liebertpub.com
Polycystic ovary syndrome (PCOS) is a common disorder characterized by
hyperandrogenism and disordered gonadotropin secretion, often associated with insulin …